Gram-Negative Bacterial Infection Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Gram-Negative Bacterial Infection Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gram-Negative Bacterial Infection Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gram-Negative Bacterial Infection Therapeutics Overall Market Size
2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size: 2022 VS 2030
2.2 Global Gram-Negative Bacterial Infection Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gram-Negative Bacterial Infection Therapeutics Players in Global Market
3.2 Top Global Gram-Negative Bacterial Infection Therapeutics Companies Ranked by Revenue
3.3 Global Gram-Negative Bacterial Infection Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Gram-Negative Bacterial Infection Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gram-Negative Bacterial Infection Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gram-Negative Bacterial Infection Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Gram-Negative Bacterial Infection Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Gram-Negative Bacterial Infection Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gram-Negative Bacterial Infection Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Enteral Treatment
4.1.3 Parenteral Treatment
4.1.4 Topical Treatment
4.2 By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gram-Negative Bacterial Infection Therapeutics Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Gram-Negative Bacterial Infection Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Gram-Negative Bacterial Infection Therapeutics Revenue, 2018-2030
6.3.2 US Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.3.3 Canada Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.3.4 Mexico Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Gram-Negative Bacterial Infection Therapeutics Revenue, 2018-2030
6.4.2 Germany Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.4.3 France Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.4.4 U.K. Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.4.5 Italy Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.4.6 Russia Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.4.8 Benelux Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Gram-Negative Bacterial Infection Therapeutics Revenue, 2018-2030
6.5.2 China Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.5.3 Japan Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.5.4 South Korea Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.5.6 India Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Gram-Negative Bacterial Infection Therapeutics Revenue, 2018-2030
6.6.2 Brazil Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.6.3 Argentina Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Revenue, 2018-2030
6.7.2 Turkey Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.7.3 Israel Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
6.7.5 UAE Gram-Negative Bacterial Infection Therapeutics Market Size, 2018-2030
7 Gram-Negative Bacterial Infection Therapeutics Companies Profiles
7.1 Baxter
7.1.1 Baxter Company Summary
7.1.2 Baxter Business Overview
7.1.3 Baxter Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
7.1.4 Baxter Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Baxter Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
7.2.4 Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
7.3.4 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
7.4.4 Novartis Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
7.5.4 Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Takeda
7.6.1 Takeda Company Summary
7.6.2 Takeda Business Overview
7.6.3 Takeda Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
7.6.4 Takeda Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Takeda Key News & Latest Developments
7.7 Nektar Therapeutics
7.7.1 Nektar Therapeutics Company Summary
7.7.2 Nektar Therapeutics Business Overview
7.7.3 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
7.7.4 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Nektar Therapeutics Key News & Latest Developments
7.8 Sumitomo
7.8.1 Sumitomo Company Summary
7.8.2 Sumitomo Business Overview
7.8.3 Sumitomo Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
7.8.4 Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Sumitomo Key News & Latest Developments
7.9 Targeted Genetics
7.9.1 Targeted Genetics Company Summary
7.9.2 Targeted Genetics Business Overview
7.9.3 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Major Product Offerings
7.9.4 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Targeted Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Gram-Negative Bacterial Infection Therapeutics Market Opportunities & Trends in Global Market
Table 2. Gram-Negative Bacterial Infection Therapeutics Market Drivers in Global Market
Table 3. Gram-Negative Bacterial Infection Therapeutics Market Restraints in Global Market
Table 4. Key Players of Gram-Negative Bacterial Infection Therapeutics in Global Market
Table 5. Top Gram-Negative Bacterial Infection Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gram-Negative Bacterial Infection Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gram-Negative Bacterial Infection Therapeutics Product Type
Table 9. List of Global Tier 1 Gram-Negative Bacterial Infection Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gram-Negative Bacterial Infection Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Gram-Negative Bacterial Infection Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gram-Negative Bacterial Infection Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Gram-Negative Bacterial Infection Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gram-Negative Bacterial Infection Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. Baxter Company Summary
Table 31. Baxter Gram-Negative Bacterial Infection Therapeutics Product Offerings
Table 32. Baxter Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Baxter Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Gram-Negative Bacterial Infection Therapeutics Product Offerings
Table 36. Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi Key News & Latest Developments
Table 38. GlaxoSmithKline Company Summary
Table 39. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product Offerings
Table 40. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. GlaxoSmithKline Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Gram-Negative Bacterial Infection Therapeutics Product Offerings
Table 44. Novartis Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Gram-Negative Bacterial Infection Therapeutics Product Offerings
Table 48. Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Takeda Company Summary
Table 51. Takeda Gram-Negative Bacterial Infection Therapeutics Product Offerings
Table 52. Takeda Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Takeda Key News & Latest Developments
Table 54. Nektar Therapeutics Company Summary
Table 55. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product Offerings
Table 56. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Nektar Therapeutics Key News & Latest Developments
Table 58. Sumitomo Company Summary
Table 59. Sumitomo Gram-Negative Bacterial Infection Therapeutics Product Offerings
Table 60. Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Sumitomo Key News & Latest Developments
Table 62. Targeted Genetics Company Summary
Table 63. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product Offerings
Table 64. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Targeted Genetics Key News & Latest Developments
List of Figures
Figure 1. Gram-Negative Bacterial Infection Therapeutics Segment by Type in 2022
Figure 2. Gram-Negative Bacterial Infection Therapeutics Segment by Application in 2022
Figure 3. Global Gram-Negative Bacterial Infection Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gram-Negative Bacterial Infection Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Gram-Negative Bacterial Infection Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gram-Negative Bacterial Infection Therapeutics Revenue in 2022
Figure 8. By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Gram-Negative Bacterial Infection Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. Baxter Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Takeda Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
